Patent directory · USPTO A61K / A61P
Patents matching “precision”
183 pharma patents match "precision" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 183 pharmaceutical patents matching "precision" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11529381
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
granted -
US 11519007
Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy
granted -
US 11505604
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 11490643
Lactobacillus casei for treating obesity and associated metabolic disorders
granted -
US 11492345
Compounds and their methods of use
granted -
US 11478430
Implantable medical devices for extended release of therapeutic agents
granted -
US 11453861
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11427540
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11400123
Combination product for prophylaxis and treatment of irritable bowel syndrome
granted -
US 11401341
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 11384335
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11345733
Colon and pancreas cancer specific antigens and antibodies
granted -
US 11317888
Non-invasive method for pressure measurement
granted -
US 11286291
Co-stimulatory domains for use in genetically-modified cells
granted -
US 11278535
Compounds and their methods of use
granted -
US 11279768
Anti-cancer antibodies, combination therapies, and uses thereof
granted -
US 11278632
Engineered nucleases useful for treatment of hemophilia A
granted -
US 11274285
Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome
granted -
US 11268065
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 11266693
Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
granted -
US 11261188
Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel
granted -
US 11225641
Probiotic Bifidobacterium strain
granted -
US 11191935
Implant delivery system with hydration promotor capability
granted -
US 11186822
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted